Skip to main content
SpringerLink
Log in

Reaching NHAS targets for HIV cost effective in USA

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2014 US dollars

References

  1. Borre ED, et al. The Clinical and Economic Impact of Attaining National HIV/AIDS Strategy Treatment Targets in the United States. Journal of Infectious Diseases : 28 Sep 2017. Available from: URL: http://doi.org/10.1093/infdis/jix349.

  2. Adimora AA. Implementing National HIV/AIDS Strategy 2015 Treatment Targets Is Cost-effective and Would Save Lives: What Other Evidence Do We Need? Journal of Infectious Diseases : 28 Sep 2017. Available from: URL: http://doi.org/10.1093/infdis/jix351.

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Reaching NHAS targets for HIV cost effective in USA. PharmacoEcon Outcomes News 790, 26 (2017). https://doi.org/10.1007/s40274-017-4471-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4471-0

Search

Navigation